BillsBills 119th Congress S. 2276 S. 2276 · Senate bill · 119th Congress
Eliminating Thickets to Increase Competition Act ETHIC Act
Introduced Jul 15, 2025 In committee Jul 15, 2025 Judiciary Passed the Senate (not yet) Passed the House (not yet) Law (not yet) What it would change (1) About this text
1 section of the Code · 1 change asked for
Text: introduced in Senate Introduced The text as a member of Congress first filed it. Most bills never get further than this. , Jul 15, 2025 (the only version so far)
Official text on Congress.gov
Written by AIWhat this bill would change in the Code
This change would add a new paragraph (7) at the end of 35 U.S.C. § 271(e) limiting patent lawsuits against generic drug and biosimilar makers. Where the defendant has applied for approval (or holds approval) of a generic drug or a biosimilar, or makes, sells or imports such a product, the patent owner could assert only one patent per "Patent Group" and could not bring later suits on another patent in the same group. A Patent Group means two or more commonly owned patents or applications linked by terminal disclaimers, which are filings that tie a patent to another to avoid double patenting. Current law has no such cap.
This is the note on the one section the bill would change. It covers only changes to the Code. No person has checked it, and it can be wrong. The changes themselves are what the bill would do. About these notes
Sections are cited like “7 U.S.C. § 2012”: title Title One of the 54 subject areas the Code is divided into, such as Title 7 (Agriculture) or Title 26 (taxes). A title is split into chapters. 7 of the United States Code U.S.C. (United States Code) The United States Code: the federal laws in force, arranged by subject. "4 U.S.C. § 8" means title 4, section 8. , section Section (§) The basic unit of the Code, marked §. Each section has a number within its title and is cited like "7 U.S.C. § 2012". 2012.
35 U.S.C. Chapter 28 · Infringement of Patents 1 section § 271 Infringement of patent Shown